Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation clinical trials

Explore recruiting previously untreated chronic lymphocytic leukemia without del 17p or tp53 mutation clinical trials.

Also recruiting in Europe

Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation (AMPLIFY)

Czechia, Slovakia, Hungary, Sweden, Bulgaria, Netherlands +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation trials by city

Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Toronto Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Vancouver Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Montreal Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Calgary Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Edmonton Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Ottawa Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Winnipeg Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Quebec City Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Hamilton Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Kitchener Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in London Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Halifax Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in New York Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Los Angeles Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Chicago Previously Untreated Chronic Lymphocytic Leukemia Without Del 17p Or Tp53 Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease